3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
4
Urinary Bladder Neoplasms
3
Neoplasm Metastasis
3
Recurrence
2
Urethral Neoplasms
1
Ureteral Neoplasms
1
Stomach Neoplasms
1
Ovarian Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Multiple Myeloma
1
Melanoma
1
Lymphoma
1
Lung Neoplasms
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Carcinoma in Situ
1
Breast Neoplasms
1
Interventions
Cytarabine
167
fludarabine phosphate
102
Cyclophosphamide
97
Azacitidine
92
Whole-Body Irradiation
78
fludarabine
77
Mycophenolic Acid
71
Busulfan
68
Tacrolimus
59
Peripheral Blood Stem Cell Transplantation
55
Decitabine
55
Granulocyte Colony-Stimulating Factor
49
Filgrastim
44
Daunorubicin
44
Cyclosporine
42
Methotrexate
41
Melphalan
41
Etoposide
41
Clofarabine
41
Idarubicin
39
Mitoxantrone
34
Antilymphocyte Serum
34
venetoclax
32
thymoglobulin
23
Thiotepa
23
Stem Cell Transplantation
21
Injections
16
Gemtuzumab
16
CPX-351
16
Sirolimus
15
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Myeloid, Acute
×
ALT-801
×
Clear all
No trials found.